ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

25,389Medicare Part D Prescriptions Filled, Including Refills

Rank: 41 out of 6969

$2.29M Total Retail Price of All Prescriptions

Rank: 21 out of 6969

695 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
95% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 695 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

44% of this provider’s 695 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

3% of this provider’s 22,485 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

45% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$90 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

37 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
AMLODIPINE BESYLATE 753 720 1 4
LIDODERM 702 619 2 75
LOVAZA 611 584 3 77
ALENDRONATE SODIUM 594 551 4 14
HYDROCODONE-ACETAMINOPHEN 543 356 S3 5 3
AMOXICILLIN 485 455 6 99
OMEPRAZOLE 463 393 7 6
AZITHROMYCIN 418 349 8 42
IBUPROFEN 404 359 9 29
IBANDRONATE SODIUM 379 355 10 10 178
METFORMIN HCL 366 323 11 7
SIMVASTATIN 358 326 12 1
NEXIUM 349 321 13 52
ACETAMINOPHEN-CODEINE 341 307 S3 14 73
ATORVASTATIN CALCIUM 341 309 14 11
GLYBURIDE-METFORMIN HCL 321 310 R 16 92
FLUOCINONIDE 311 273 17 134
DIOVAN 304 269 18 26
CEFTRIAXONE 298 275 10 19 343
FAMOTIDINE 292 283 20 37
SOLARAZE 282 222 21 314
BONIVA 274 259 10 22 198
CRESTOR 266 251 23 39
VOLTAREN 261 214 24 105
CLOPIDOGREL 251 238 25 48
MELOXICAM 243 209 26 36
ZOLPIDEM TARTRATE 238 184 27 16
CELEBREX 233 214 28 67
TRAMADOL HCL 219 176 29 27
JANUVIA 218 197 30 41
LEVOTHYROXINE SODIUM 217 163 31 5
DIOVAN HCT 214 204 32 57
TRIAMCINOLONE ACETONIDE 213 204 33 55
ATELVIA 206 190 34 111
LEVOFLOXACIN 204 166 35 109
CEPHALEXIN 203 182 36 96
PATADAY 192 185 37 213
TAMSULOSIN HCL 191 186 38 23
DEXILANT 188 156 39 110
ADVAIR DISKUS 185 164 40 45
ATENOLOL 184 177 41 9
PLAVIX 183 174 42 68
DEXTROSE WITH SODIUM CHLORIDE 182 180 10 43 423
LANSOPRAZOLE 169 157 44 171
ALLOPURINOL 159 149 45 35
AMLODIPINE BESYLATE-BENAZEPRIL 159 137 45 91
FUROSEMIDE 154 129 47 10
NIFEDIPINE ER 153 142 48 95
ACTONEL 150 148 49 115
PROAIR HFA 150 127 49 33
LOSARTAN POTASSIUM 148 135 51 12
VIMOVO 138 102 10 52 404
FENOFIBRATE 131 120 53 63
KLOR-CON 8 131 109 53 104
BENAZEPRIL HCL 130 122 55 18
SODIUM CHLORIDE 129 124 56 242
SYMBICORT 123 114 57 149
ACTOS 123 117 57 61
DONEPEZIL HCL 118 118 59 32
GLIPIZIDE 115 115 60 21
AZOR 115 114 60 233
SINGLE USE SWAB 115 114 60 306
METOPROLOL SUCCINATE 111 107 63 22
CLOTRIMAZOLE-BETAMETHASONE 111 86 63 182
ZOSTAVAX 110 97 65 79
PANTOPRAZOLE SODIUM 110 92 65 31
NASONEX 109 95 67 144
FLUTICASONE PROPIONATE 104 89 68 24
PRAVASTATIN SODIUM 103 95 69 19
CARVEDILOL 102 101 70 25
PROPRANOLOL HCL 102 86 70 153
PRAMIPEXOLE DIHYDROCHLORIDE 101 88 72 227
BENICAR 98 94 73 107
PATANOL 92 82 74 142
TAMIFLU 91 80 75 340
SINGULAIR 90 89 76 84
NAPROXEN 90 63 76 62
DIGOXIN 85 75 78 71
GABAPENTIN 84 70 79 17
POLYETHYLENE GLYCOL 3350 83 71 80 127
DIPHENOXYLATE-ATROPINE 81 77 81 214
AZELASTINE HCL 80 76 82 376
KETOROLAC TROMETHAMINE 78 58 R 83 448
AVODART 78 77 83 108
NAPHAZOLINE HCL 77 73 85 245
COMBIVENT 76 61 86 170
ISOSORBIDE MONONITRATE ER 76 72 86 81
LIPITOR 75 69 88 89
CARISOPRODOL 75 27 R 88 69
ZETIA 73 71 90 98
CLONIDINE HCL 73 73 90 59
TERAZOSIN HCL 71 71 92 49
OXYCODONE HCL 70 11 S2 93 117
FLECTOR 70 51 93 264
HYDROXYZINE HCL 69 63 R 95 159
DICLOFENAC SODIUM 69 64 95 78
CIPROFLOXACIN HCL 66 60 97 64
LISINOPRIL 65 56 98 2
NYSTATIN-TRIAMCINOLONE 65 61 98 278
EXFORGE 65 60 98 190
LIVALO 64 56 101 332
NITROSTAT 62 54 102 210
NATEGLINIDE 62 62 102 228
SPIRIVA 61 46 104 66
CYMBALTA 61 47 104 72
MORPHINE SULFATE ER 61 52 S2 104 90
MEGESTROL ACETATE 61 53 R 104 129
NAMENDA 60 60 108 51
MEGACE ES 60 56 R 108 442
EXELON 60 59 108 157
JALYN 59 57 111 339
PROLIA 58 54 112 386
CREON 57 47 113 147
CARBIDOPA-LEVODOPA 57 57 113 119
METOPROLOL TARTRATE 57 55 113 13
EVISTA 54 51 116 118
EFFIENT 54 51 116 272
MUPIROCIN 54 43 116 291
TOBRADEX 53 46 119 599
METAPROTERENOL SULFATE 53 51 10 119 414
DICYCLOMINE HCL 53 44 119 317
BENICAR HCT 53 51 119 176
MONTELUKAST SODIUM 51 50 123 151
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 1, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.